Lupin Launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in the United States

MUMBAI, India and NAPLES, Fla., April 22, 2026 /PRNewswire/ -- Global pharmaceutical leader Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets, 5 mg/500...